FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
April 11, 2007
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
Form 20-F X Form 40-F
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
Yes No X
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
Yes No X
--- ---
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
Yes No X
--- ---
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Smith & Nephew plc
(Registrant)
Date: April 11, 2007
By: /s/ Paul Chambers
-----------------
Paul Chambers
Company Secretary
Timing of Smith & Nephew First Quarter Results
11 April 2007
Smith & Nephew plc will be announcing its results for the first quarter ending
31 March 2007 on Thursday 3 May 2007 at 11am BST/6am Eastern. A presentation for
financial analysts will be held at 11.45am BST/6.45am Eastern, which can be
heard live via webcast on the Smith & Nephew website at www.smith-nephew.com and
available on the site archive shortly afterwards.
About Us
Smith & Nephew (LSE: SN, NYSE:SNN) is one of the world's leading medical devices
companies, specialising in Orthopaedic Reconstruction, Orthopaedic Trauma and
Clinical Therapies, Endoscopy and Advanced Wound Management. Smith & Nephew
ranks as the global leader in arthroscopy and advanced wound management and is
the fastest growing full-line orthopaedics company in the world.
Smith & Nephew is dedicated to helping improve people's lives. The company
prides itself on the strength of its relationships with its surgeon and
healthcare professional customers, with whom its name is synonymous with the
highest standards of performance, innovation and trust. The company has over
8,800 employees and operates in 31 countries around the world, generating sales
of $2.8 billion.
Enquiries:
Smith & Nephew UK
Julie Allen Tel: +44 (0)20 7401 7646
Investor Relations Co-ordinator
Financial Dynamics UK
David Yates/Ben Atwell Tel: +44 (0)20 7831 3113
Financial Dynamics US
Jonathan Birt Tel: +1 212 850 5634